DIO 902

Drug Profile

DIO 902

Alternative Names: (2S,4R)-ketoconazole; DIO-902; levdexketoconazole

Latest Information Update: 25 Mar 2017

Price : $50

At a glance

  • Originator Cortendo
  • Developer DiObex
  • Class Imidazoles; Piperazines
  • Mechanism of Action 14-alpha demethylase inhibitors; Steroid 11-beta-hydroxylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Type 2 diabetes mellitus

Most Recent Events

  • 05 Feb 2009 Discontinued - Phase-II for Type-2 diabetes mellitus in Australia (PO)
  • 05 Feb 2009 Discontinued - Phase-II for Type-2 diabetes mellitus in New Zealand (PO)
  • 05 Feb 2009 Discontinued - Phase-II for Type-2 diabetes mellitus in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top